Mechelen, Belgium, Leiden, the Netherlands, Pittsburgh, Pennsylvania, United States; 21 June 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG), CellPoint and AboundBio today announced that…
CELlPOINT AND HYPERTRUST CO-DEVELOP xCELLIT platform for cell therapies at the point of care Leiden (NL) / Munich (DE) – November 2021 – CellPoint and Hypertrust Patient Data Care…